Near-Infrared Light-Activated Oxygen Generator a Multidynamic Photo-Nanoplatform for Effective Anti-Cutaneous

Xin Zhang1,2,3, Xiangbo Bu4, Wenyu Jia1,2

  • 1Department of Dermatology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, People's Republic of China.

Abstract

Insights

This study introduces a novel nanocomposite (TSL-IR820-CAT) for enhanced photodynamic therapy (PDT) and photothermal therapy (PTT) in skin cancer. Gas-liquid injection improves treatment efficacy and minimizes side effects for cutaneous squamous cell carcinoma (cSCC).

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Dermatology
  • Oncology

Background:

  • Nanophototherapy shows promise for cancer treatment but has limited efficacy for skin tumors.
  • Existing treatments for cutaneous squamous cell carcinoma (cSCC) require enhancement for better outcomes.
  • Synergistic approaches combining photodynamic therapy (PDT) and photothermal therapy (PTT) are being explored.

Purpose of the Study:

  • To develop and evaluate a novel oxygen-generating nanocomposite for enhanced cancer therapy.
  • To investigate the combined PDT/PTT effects of the nanocomposite using a gas-liquid injection technique for cSCC treatment.
  • To assess the efficacy and safety of the developed therapeutic strategy in preclinical models.

Main Methods:

  • Synthesis of a thermosensitive liposome-encapsulated nanocomposite (TSL-IR820-CAT) containing IR820 and catalase.
  • Utilized a gas-liquid injection technique for efficient delivery of the nanocomposite into tumor tissue.
  • Evaluated the in vitro and in vivo therapeutic effects on cSCC, including cellular uptake, oxygen generation, apoptosis induction, and tumor inhibition.

Main Results:

  • Successfully developed TSL-IR820-CAT with good stability, drug release, and photothermal conversion.
  • Injected nanoparticles efficiently accumulated in tumor tissue, with localized oxygen production enhancing PDT efficacy.
  • Combined PDT/PTT therapy induced irreversible apoptosis, inhibited cSCC growth, and showed no apparent systemic side effects.

Conclusions:

  • The developed TSL-IR820-CAT nanocomposite effectively enhances PDT/PTT synergistic therapy for cSCC.
  • Gas-liquid injection is a viable technique for improving the delivery and efficacy of nanomedicines in skin cancer treatment.
  • This approach offers a promising strategy with significant application value for treating skin tumors and precancerous lesions.

Related Concept Videos